Sambhawana Bhandari
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
Hyperleukocytosis is defined as a white blood cell count exceeding 100,000/µL and is a critical manifestation of acute and chronic leukemia. It can lead to life‐threatening complications such as leukostasis, disseminated intravascular coagulation, and tumor lysis syndrome. Leukostasis results from microvascular obstruction by leukemic blasts, causing multisystemic manifestations. Leukostasis is primarily a clinical diagnosis requiring prompt recognition and intervention. Supportive care includes intravenous hydration, uric acid‐lowering agents, and cautious blood transfusions to prevent worsening hyperviscosity. Hydroxyurea and cytarabine are used as cytoreductive agents until a definitive diagnosis and management are started. The role of leukapheresis is controversial, and practice patterns differ between clinicians and institutions.
Year:
2026
Year:
2026
Year:
2025
Anti-melanoma differentiation-associated gene 5 (MDA-5) dermatomyositis (DM) is noteworthy for its association with rapidly progressive interstitial lung disease (RP-ILD), vasculopathy, and distinctive cutaneous features. First identified in a Japanese cohort in 2005, MDA-5 DM carries a significant mortality risk, emphasizing the crucial need for early diagnosis. This review explores the pathogenesis, clinical presentation, diagnosis, management, and prognosis of MDA-5 DM and ILD and includes new research and recommendations regarding disease management.
Year:
2024
Year:
2024
Rheumatoid Arthritis (RA) is a systemic inflammatory disorder that commonly presents with polyarthritis but can have multisystemic involvement and complications, leading to increased morbidity and mortality. The diagnosis of RA continues to be challenging due to its varied clinical presentations. In this review article, we aim to determine the potential of PET/CT to assist in the diagnosis of RA and its complications, evaluate the therapeutic response to treatment, and predict RA remission. PET/CT has increasingly been used in the last decade to diagnose, monitor treatment response, predict remissions, and diagnose subclinical complications in RA. PET imaging with [ 18 F]-fluorodeoxyglucose ([ 18 F]-FDG) is the most commonly applied radiotracer in RA, but other tracers are also being studied. PET/CT with [ 18 F]-FDG, [ 18 F]-NaF, and other tracers might lead to early identification of RA and timely evidence-based clinical management, decreasing morbidity and mortality. Although PET/CT has been evolving as a promising tool for evaluating and managing RA, more evidence is required before incorporating PET/CT in the standard clinical management of RA.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (2)
Lisa Zickuhr
Washington University in Saint Louis School of Medicine
Ajay Singh
Professor
University of Mississippi Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.